Your browser doesn't support javascript.
loading
Augmented neutralization of SARS-CoV-2 Omicron variant by boost vaccination and monoclonal antibodies.
Schulz, Sebastian R; Hoffmann, Markus; Roth, Edith; Pracht, Katharina; Burnett, Deborah L; Mazigi, Ohan; Schuh, Wolfgang; Manger, Bernhard; Mielenz, Dirk; Goodnow, Christopher C; Christ, Daniel; Pöhlmann, Stefan; Jäck, Hans-Martin.
Afiliación
  • Schulz SR; Division of Molecular Immunology, Department of Internal Medicine 3, Nikolaus-Fiebiger-Zentrum, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany.
  • Hoffmann M; Infection Biology Unit, German Primate Center-Leibniz Institute for Primate Research, Göttingen, Germany.
  • Roth E; Faculty of Biology and Psychology, University of Göttingen, Göttingen, Germany.
  • Pracht K; Division of Molecular Immunology, Department of Internal Medicine 3, Nikolaus-Fiebiger-Zentrum, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany.
  • Burnett DL; Division of Molecular Immunology, Department of Internal Medicine 3, Nikolaus-Fiebiger-Zentrum, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany.
  • Mazigi O; Garvan Institute of Medical Research, Sydney, New South Wales, Australia.
  • Schuh W; Faculty of Medicine, UNSW, St. Vincent's Clinical School, Sydney, New South Wales, Australia.
  • Manger B; Garvan Institute of Medical Research, Sydney, New South Wales, Australia.
  • Mielenz D; Faculty of Medicine, UNSW, St. Vincent's Clinical School, Sydney, New South Wales, Australia.
  • Goodnow CC; Division of Molecular Immunology, Department of Internal Medicine 3, Nikolaus-Fiebiger-Zentrum, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany.
  • Christ D; Department of Internal Medicine 3, University Hospital Erlangen, Erlangen, Bavaria, Germany.
  • Pöhlmann S; Division of Molecular Immunology, Department of Internal Medicine 3, Nikolaus-Fiebiger-Zentrum, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany.
  • Jäck HM; Garvan Institute of Medical Research, Sydney, New South Wales, Australia.
Eur J Immunol ; 52(6): 970-977, 2022 06.
Article en En | MEDLINE | ID: mdl-35253229
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antineoplásicos Inmunológicos / COVID-19 Límite: Humans Idioma: En Revista: Eur J Immunol Año: 2022 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antineoplásicos Inmunológicos / COVID-19 Límite: Humans Idioma: En Revista: Eur J Immunol Año: 2022 Tipo del documento: Article País de afiliación: Alemania